Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association.

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.

2.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ.

Alzheimers Dement. 2012 Jan;8(1):1-13. doi: 10.1016/j.jalz.2011.10.007.

3.

Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.

Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Kamboh MI, Kofler JK, Mash DC, Duque L, Gilbert JR, Gwirtsman H, Buxbaum JD, Kramer P, Dickson DW, Farrer LA, Frosch MP, Ghetti B, Haines JL, Hyman BT, Kukull WA, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Reiman EM; Alzheimer's Disease Genetics Consortium (ADGC), Schellenberg GD, Montine TJ.

PLoS Genet. 2014 Sep 4;10(9):e1004606. doi: 10.1371/journal.pgen.1004606. eCollection 2014 Sep. Erratum in: PLoS Genet. 2014 Nov;10(11):e1004867.

4.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
6.

Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.

Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, Frosch M, Henriksen J, Kofler J, Kukull WA, Lee EB, Nelson PT, Schantz AM, Schneider JA, Sonnen JA, Trojanowski JQ, Vinters HV, Zhou XH, Hyman BT.

Alzheimers Dement. 2016 Feb;12(2):164-9. doi: 10.1016/j.jalz.2015.07.492. Epub 2015 Aug 29.

7.

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Beach TG, Monsell SE, Phillips LE, Kukull W.

J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73. doi: 10.1097/NEN.0b013e31824b211b.

8.

Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.

Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H.

Brain Res. 2007 Dec 12;1184:284-94. Epub 2007 Oct 25.

PMID:
17963732
9.

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.

Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M.

Am J Geriatr Psychiatry. 2008 Feb;16(2):168-74. doi: 10.1097/JGP.0b013e31816029ec.

PMID:
18239198
10.

Diagnostic criteria for the neuropathologic assessment of Alzheimer's disease.

Powers JM.

Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S53-4.

PMID:
9330986
11.

Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.

Marui W, Iseki E, Kato M, Akatsu H, Kosaka K.

Acta Neuropathol. 2004 Aug;108(2):121-8. Epub 2004 May 14.

PMID:
15235805
12.

Alzheimer's disease-related plaques in nondemented subjects.

Elobeid A, Rantakömi S, Soininen H, Alafuzoff I.

Alzheimers Dement. 2014 Sep;10(5):522-9. doi: 10.1016/j.jalz.2012.12.009. Epub 2014 Apr 16.

PMID:
24742915
13.

TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM.

Acta Neuropathol. 2011 Dec;122(6):703-13. doi: 10.1007/s00401-011-0879-y. Epub 2011 Oct 4.

PMID:
21968532
14.

Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.

Flanagan ME, Marshall DA, Shofer JB, Montine KS, Nelson PT, Montine TJ, Keene CD.

J Neuropathol Exp Neurol. 2017 Jan 1;76(1):39-43. doi: 10.1093/jnen/nlw104.

PMID:
28062571
15.

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

Braak H, Braak E.

Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S85-8.

PMID:
9330992
16.

Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.

Rohn TT.

Brain Res. 2008 Sep 4;1228:189-98. doi: 10.1016/j.brainres.2008.06.094. Epub 2008 Jul 2.

17.

Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.

Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT.

Brain. 2014 Jan;137(Pt 1):255-67. doi: 10.1093/brain/awt318. Epub 2013 Nov 21.

18.

Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease.

Jellinger KA, Bancher C.

Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S55-65. Review.

PMID:
9330987
19.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

Supplemental Content

Support Center